UB Paderborn / Katalog / Suche / in CDI

Dynamic historical data borrowing using weighted average

Journal of the Royal Statistical Society Series C: Applied Statistics, 2021-11, Vol.70 (5), p.1259-1280

2021

Volltextzugriff (PDF)

A confirmatory basket design considering non-inferiority and superiority testing

Journal of biopharmaceutical statistics, 2024-03, Vol.34 (2), p.205-221

2024

Volltextzugriff (PDF)

Effect of Single Oral Doses of Sitagliptin, a Dipeptidyl Peptidase-4 Inhibitor, on Incretin and Plasma Glucose Levels after an Oral Glucose Tolerance Test in Patients with Type 2 Diabetes

The journal of clinical endocrinology and metabolism, 2006-11, Vol.91 (11), p.4612-4619

2006

Volltextzugriff (PDF)

Effect of Renal Insufficiency on the Pharmacokinetics of Sitagliptin, a Dipeptidyl Peptidase-4 Inhibitor

Diabetes care, 2007-07, Vol.30 (7), p.1862-1864

2007

Volltextzugriff (PDF)

Tolerability and pharmacokinetics of metformin and the dipeptidyl peptidase-4 inhibitor sitagliptin when co-administered in patients with type 2 diabetes

Current medical research and opinion, 2006-10, Vol.22 (10), p.1939-1947

2006

Volltextzugriff (PDF)

Pharmacokinetic and pharmacodynamic properties of multiple oral doses of sitagliptin, a dipeptidyl peptidase-IV inhibitor: A double-blind, randomized, placebo-controlled study in healthy male volunteers

Clinical therapeutics, 2006, Vol.28 (1), p.55-72

2006

Volltextzugriff (PDF)

An orally active calcium-sensing receptor antagonist that transiently increases plasma concentrations of PTH and stimulates bone formation

Bone (New York, N.Y.), 2010-02, Vol.46 (2), p.534-542

2010

Volltextzugriff (PDF)

Evaluation of pharmacokinetic parameters and dipeptidyl peptidase‐4 inhibition following single doses of sitagliptin in healthy, young Japanese males

British journal of clinical pharmacology, 2011-03, Vol.71 (3), p.429-436

2011

Volltextzugriff (PDF)

Indirect Comparison of Ropinirole and Pramipexole as Levodopa Adjunctive Therapy in Advanced Parkinson’s Disease: A Systematic Review and Network Meta-Analysis

Advances in therapy, 2019-06, Vol.36 (6), p.1252-1265

2019

Volltextzugriff (PDF)

Pharmacokinetics and pharmacodynamics of sitagliptin, an inhibitor of dipeptidyl peptidase IV, in healthy subjects: Results from two randomized, double-blind, placebo-controlled studies with single oral doses

Clinical pharmacology and therapeutics, 2005-12, Vol.78 (6), p.675-688

2005

Volltextzugriff (PDF)

Clinical Trial Design and Analysis Considerations for Rare Diseases

Drug Development for Rare Diseases, 2023, p.35-100

1, 2023

Volltextzugriff (PDF)

Co-Administration of MK-0431 and Metformin in Patients with Type 2 Diabetes Does Not Alter the Pharmacokinetics of MK-0431 or Metformin

Diabetes (New York, N.Y.), 2005-06, Vol.54, p.A505

2005

Volltextzugriff (PDF)

Lack of a Clinically Meaningful Effect on Age, Gender or Obesity on the Pharmacokinetics of the DPP-IV Inhibitor MK-0431

Diabetes (New York, N.Y.), 2005-06, Vol.54, p.A506

2005

Volltextzugriff (PDF)

Single Doses of MK-0431, an Inhibitor of Dipeptidyl Peptidase-IV, Raise Active GLP-1 Levels without Causing Hypoglycemia in Healthy Subjects

Diabetes (New York, N.Y.), 2005-06, Vol.54, p.A122

2005

Volltextzugriff (PDF)

Coadministration of PDE-5 inhibitors with gatifloxacin has minimal effect on the QTc interval in healthy male subjects

Journal of electrocardiology, 2007-07, Vol.40 (4), p.S56-S56

2007

Volltextzugriff (PDF)

Nonparametric, parametric and semiparametric models for screening and decoding pools of chemical compounds

Yi, Bingming

2002

Volltextzugriff (PDF)

Pharmacoldnetics and pharmacodynamics of sitagliptin, an inhibitor of dipeptidyl peptidase IV, in healthy subjects : Results from two randomized, double-blind, placebo- controlled studies with single oral doses

Clinical pharmacology and therapeutics, 2005, Vol.78 (6), p.675-688

2005

Volltextzugriff (PDF)

A Factorial Design to Optimize Cell-Based Drug Discovery Analysis

ChemInform, 2002-12, Vol.33 (50), p.214-214

2002

Volltextzugriff (PDF)

A Factorial Design To Optimize Cell-Based Drug Discovery Analysis

Journal of Chemical Information and Computer Sciences, 2002-09, Vol.42 (5), p.1221-1229

2002

Volltextzugriff (PDF)

Impact of acquisition of 16S rRNA methylase RmtB on the fitness of Escherichia coli

Journal of global antimicrobial resistance., 2016-09, Vol.6, p.32-38

2016

Volltextzugriff (PDF)

甜菜夜蛾核多角体病毒VP39蛋白在苜蓿丫纹夜蛾核多角体病毒中的功能研究

南方农业学报, 2021, Vol.52 (6), p.1440-1449

2021

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

Dynamic historical data borrowing using weighted average

A confirmatory basket design considering non-inferiority and superiority testing

Effect of Single Oral Doses of Sitagliptin, a Dipeptidyl Peptidase-4 Inhibitor, on Incretin and Plasma Glucose Levels after an Oral Glucose Tolerance Test in Patients with Type 2 Diabetes

Effect of Renal Insufficiency on the Pharmacokinetics of Sitagliptin, a Dipeptidyl Peptidase-4 Inhibitor

Tolerability and pharmacokinetics of metformin and the dipeptidyl peptidase-4 inhibitor sitagliptin when co-administered in patients with type 2 diabetes

Pharmacokinetic and pharmacodynamic properties of multiple oral doses of sitagliptin, a dipeptidyl peptidase-IV inhibitor: A double-blind, randomized, placebo-controlled study in healthy male volunteers

An orally active calcium-sensing receptor antagonist that transiently increases plasma concentrations of PTH and stimulates bone formation

Evaluation of pharmacokinetic parameters and dipeptidyl peptidase‐4 inhibition following single doses of sitagliptin in healthy, young Japanese males

Indirect Comparison of Ropinirole and Pramipexole as Levodopa Adjunctive Therapy in Advanced Parkinson’s Disease: A Systematic Review and Network Meta-Analysis

Pharmacokinetics and pharmacodynamics of sitagliptin, an inhibitor of dipeptidyl peptidase IV, in healthy subjects: Results from two randomized, double-blind, placebo-controlled studies with single oral doses

Clinical Trial Design and Analysis Considerations for Rare Diseases

Co-Administration of MK-0431 and Metformin in Patients with Type 2 Diabetes Does Not Alter the Pharmacokinetics of MK-0431 or Metformin

Lack of a Clinically Meaningful Effect on Age, Gender or Obesity on the Pharmacokinetics of the DPP-IV Inhibitor MK-0431

Single Doses of MK-0431, an Inhibitor of Dipeptidyl Peptidase-IV, Raise Active GLP-1 Levels without Causing Hypoglycemia in Healthy Subjects

Coadministration of PDE-5 inhibitors with gatifloxacin has minimal effect on the QTc interval in healthy male subjects

Nonparametric, parametric and semiparametric models for screening and decoding pools of chemical compounds

Pharmacoldnetics and pharmacodynamics of sitagliptin, an inhibitor of dipeptidyl peptidase IV, in healthy subjects : Results from two randomized, double-blind, placebo- controlled studies with single oral doses

A Factorial Design to Optimize Cell-Based Drug Discovery Analysis

A Factorial Design To Optimize Cell-Based Drug Discovery Analysis

Impact of acquisition of 16S rRNA methylase RmtB on the fitness of Escherichia coli

甜菜夜蛾核多角体病毒VP39蛋白在苜蓿丫纹夜蛾核多角体病毒中的功能研究

Suchergebnisse filtern